Gonnade N, et al. - Authors comparatively scrutinized the treatment effectiveness of botulinum toxin type A (BTX-A) and phenol blocks in the management of lower limb spasticity in ambulatory children with cerebral palsy (CP) spastic diplegia, aged from 4 to 10 years. They also intended to estimate the improvement in gross motor functional outcome in such children. It was determined that BTX-A injections exhibited superior treatment effects in the reduction of spasticity and improvement in active range of motion (AROM) and functional outcome measures with spastic diplegia than with phenol blocks. Furthermore, BTX-A injections presented with fewer clinical side effects and appeared to be well tolerated by children with CP.